Total Payments
$111,780
2024 Payments
$1,477
Companies
39
Transactions
494
Medicare Patients
18,180
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$66,888 (59.8%)
Other$17,960 (16.1%)
Travel$15,379 (13.8%)
Food & Beverage$11,099 (9.9%)
Education$453.46 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $66,888 | 17 | 59.8% |
| Travel and Lodging | $15,379 | 32 | 13.8% |
| Honoraria | $13,800 | 4 | 12.3% |
| Food and Beverage | $11,099 | 434 | 9.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,160 | 1 | 3.7% |
| Education | $453.46 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $35,045 | 52 | $0 (2024) |
| Allergan Inc. | $16,631 | 29 | $0 (2017) |
| Galderma International SAS | $16,351 | 6 | $0 (2019) |
| VYNE Pharmaceuticals Inc. | $14,222 | 11 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $6,430 | 14 | $0 (2024) |
| Mayne Pharma Inc. | $4,711 | 8 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $3,774 | 2 | $0 (2017) |
| Janssen Research & Development, LLC | $3,500 | 1 | $0 (2018) |
| Arcutis Biotherapeutics, Inc. | $2,456 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $1,357 | 69 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,477 | 69 | Janssen Biotech, Inc. ($329.88) |
| 2023 | $4,002 | 69 | Arcutis Biotherapeutics, Inc. ($2,456) |
| 2022 | $1,071 | 57 | ABBVIE INC. ($332.35) |
| 2021 | $8,301 | 71 | Galderma Laboratories, L.P. ($6,318) |
| 2020 | $14,425 | 15 | VYNE Pharmaceuticals Inc. ($14,207) |
| 2019 | $21,405 | 50 | Galderma International SAS ($16,351) |
| 2018 | $29,712 | 61 | Galderma Laboratories, L.P. ($19,097) |
| 2017 | $31,387 | 102 | Allergan Inc. ($16,631) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Immunology | ||||||
| 10/28/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: BioOncology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 10/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.30 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DERMATOLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Immunology | ||||||
| 07/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 4,059 | 6,405 | $1.3M | $283,172 |
| 2022 | 16 | 4,378 | 6,873 | $1.0M | $269,060 |
| 2021 | 21 | 5,029 | 8,413 | $1.0M | $318,478 |
| 2020 | 19 | 4,714 | 7,291 | $581,719 | $266,932 |
Total Patients
18,180
Total Services
28,982
Medicare Billing
$1.1M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,180 | 1,393 | $373,600 | $79,972 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 587 | 748 | $289,404 | $67,111 | 23.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 777 | 990 | $200,445 | $42,873 | 21.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 322 | 355 | $109,417 | $25,011 | 22.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 235 | 255 | $88,248 | $21,052 | 23.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 541 | 2,230 | $45,116 | $10,755 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 136 | 136 | $45,807 | $10,365 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $38,313 | $8,850 | 23.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 31 | $16,869 | $4,221 | 25.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 15 | $13,641 | $3,230 | 23.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 19 | $9,752 | $2,537 | 26.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $8,526 | $1,817 | 21.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $6,829 | $1,813 | 26.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 44 | $6,705 | $1,693 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 70 | $11,339 | $1,607 | 14.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,969 | $263.78 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,482 | 1,891 | $403,952 | $110,995 | 27.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 853 | 1,048 | $176,629 | $43,166 | 24.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 378 | 427 | $109,472 | $29,011 | 26.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 233 | 241 | $69,073 | $19,791 | 28.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 622 | 2,411 | $40,144 | $11,976 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 144 | 144 | $39,954 | $10,170 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 280 | 303 | $38,521 | $10,120 | 26.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 47 | 49 | $22,108 | $6,601 | 29.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 151 | 151 | $28,164 | $6,272 | 22.3% |
About Guy Webster, MD, PHD
Guy Webster, MD, PHD is a Dermatology healthcare provider based in Hockessin, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831281138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Guy Webster, MD, PHD has received a total of $111,780 in payments from pharmaceutical and medical device companies, with $1,477 received in 2024. These payments were reported across 494 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($66,888).
As a Medicare-enrolled provider, Webster has provided services to 18,180 Medicare beneficiaries, totaling 28,982 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Hockessin, DE
- Active Since 09/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1831281138
Products in Payments
- EPIDUO FORTE (Drug) $20,977
- SOOLANTRA (Drug) $16,534
- ORACEA (Drug) $13,709
- AMZEEQ (Drug) $9,722
- ACZONE (Drug) $8,283
- SILIQ (Drug) $6,094
- DORYX (Drug) $4,711
- ZILXI (Drug) $4,500
- Seysara (Drug) $862.28
- TREMFYA (Drug) $776.68
- TALTZ (Drug) $669.55
- OPZELURA (Drug) $587.48
- SKYRIZI (Biological) $509.99
- EUCRISA (Drug) $436.41
- DUPIXENT (Biological) $429.27
- Humira (Biological) $396.69
- Tremfya (Drug) $338.51
- ILUMYA (Biological) $293.68
- COSENTYX (Biological) $262.18
- Otezla (Drug) $224.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.